IHEALTHSCREEN, INC.

Medtech · Private

AI-based software for screening, early diagnosis, and prediction of age-related macular degeneration (AMD) from retinal imaging

Grants
$4.2M
14 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
12
4 granted · 8 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · A Novel Image Based Screening System for Early Detection of Age-related Macular Degeneration$241,202
Federal grantDepartment of Health and Human Services · Phase I · A Novel Image Based Screening System for Early Detection of Age-related Macular Degeneration$25,000
Federal grantDepartment of Health and Human Services · Phase I · A Novel Image Based Screening System for Early Detection of Age-related Macular Degeneration$22,492
Federal grantDepartment of Health and Human Services · Phase I · Prediction Model for Incident Stroke for Early Screening of an Individual at Risk of Stroke$303,622
Federal grantDepartment of Health and Human Services · Phase I · Prediction Model for Incident Stroke for Early Screening of an Individual at Risk of Stroke$50,000
Federal grantDepartment of Health and Human Services · Phase I · Prediction Model for Incident Stroke for Early Screening of an Individual at Risk of Stroke$45,747
Federal grantDepartment of Health and Human Services · Phase II · A Model for Predicting 2-Year Risk of Incident Late Age-related Macular Degeneration$585,067
Federal grantDepartment of Health and Human Services · Phase II · A Model for Predicting 2-Year Risk of Incident Late Age-related Macular Degeneration$45,000
Federal grantDepartment of Health and Human Services · Phase II · A Model for Predicting 2-Year Risk of Incident Late Age-related Macular Degeneration$545,819
Federal grantDepartment of Health and Human Services · Phase II · A Model for Predicting 2-Year Risk of Incident Late Age-related Macular Degeneration$108,049
Federal grantDepartment of Health and Human Services · Phase II · A Model for Predicting 2-Year Risk of Incident Late Age-related Macular Degeneration$105,300
Federal grantDepartment of Health and Human Services · Phase II · A Model for Predicting 2-Year Risk of Incident Late Age-related Macular Degeneration$369,019
Federal grantDepartment of Health and Human Services · Phase II · A Model for Predicting 2-Year Risk of Incident Late Age-related Macular Degeneration$1,049,010
Federal grantDepartment of Health and Human Services · Phase II · A Model for Predicting 2-Year Risk of Incident Late Age-related Macular Degeneration$698,032
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1890SynchNeuro——
1891NONAGEN BIOSCIENCE CORPORATION——
1892ALPACURE LLC——
1893IHEALTHSCREEN, INC.——
1894Looking Glass Productions, LLC—$125K
1895REQUISITE BIOMEDICAL, LLC——
1896POWERSCOPE, INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 4 granted of 12

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.